Syngene International Ltd.

NSE: SYNGENE | BSE: 539268 | ISIN: INE398R01022 | Industry: Pharmaceuticals
| Slowing Down Stock
404.6500 11.55 (2.94%)
NSE Apr 10, 2026 15:31 PM
Volume: 2.6M
 

404.65
2.94%
Axis Direct
Q2FY18 revenue grew 11% YoY (14% in cc terms), as growth is accelerating after the fire incident (6% YoY in Q1). EBITDA margin was healthy at 33.9% despite 22% YoY growth in staff cost and 14% YoY growth in other expenses. Revenue grew 12% YoY in cc terms in H1FY18.
Number of FII/FPI investors decreased from 293 to 265 in Dec 2025 qtr
More from Syngene International Ltd.
Recommended